Major Vascular Resection as Part of Pancreaticoduodenectomy for Cancer: Radiologic, Intraoperative, and Pathologic Analysis

Journal of Gastrointestinal Surgery

Volumn 3, Issue 3, 1999, Pages 233-243

  Bold, Richard J ^a   Charnsangavej, Chusilp ^a   Cleary, Karen R ^a   Jennings, Mary ^a   Madary, Alice ^a   Leach, Steven D ^a   Abbruzzese, Jamesl ^a   Pisters, Peter W T ^a   Lee, Jeffrey E ^a   Evans, Douglas B ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Pancreatic cancer; Pancreaticoduodenectomy; Vascular resection

Indexed keywords

CONTRAST MEDIUM;

ADENOCARCINOMA; ADJUVANT THERAPY; ARTICLE; CANCER INVASION; CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FORECASTING; HEPATIC ARTERY; HUMAN; IMAGE QUALITY; INFERIOR CAVA VEIN; MALE; MESENTERIC VEIN; METHODOLOGY; MIDDLE AGED; PANCREAS; PANCREAS TUMOR; PANCREATICODUODENECTOMY; PATHOLOGY; PEROPERATIVE CARE; PORTAL VEIN; RADIOGRAPHY; SUPERIOR MESENTERIC ARTERY; SURVIVAL RATE; VASCULAR SURGERY; VASCULARIZATION;

ADENOCARCINOMA; CARCINOMA, NEUROENDOCRINE; CONTRAST MEDIA; FEMALE; FORECASTING; HEPATIC ARTERY; HUMANS; INTRAOPERATIVE CARE; MALE; MESENTERIC ARTERY, SUPERIOR; MESENTERIC VEINS; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; PANCREAS; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PORTAL VEIN; RADIOGRAPHIC IMAGE ENHANCEMENT; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; VASCULAR SURGICAL PROCEDURES; VENA CAVA, INFERIOR;

EID: 0033122779     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(99)80065-1     Document Type: Article

References (37)

1. Evans DB, Abbruzzese JL, Rich TA. Cancer of the pancreas. In DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology, 5th ed. Philadelphia: JB Lippincott, 1997, pp 1054-1087.
2. Kelsen DP, Portenoy R, Thaler H. Pain as a predictor of outcome in patients with operable pancreatic carcinoma. Surgery 1997;123:53-59.
3. Rooij PD, Rogatko A, Brennan MF. Evaluation of palliative surgical procedures in unresectable pancreatic cancer. Br J Surg 1991;78:1053-1058.
4. Lillemoe KD. Current management of pancreatic carcinoma. Ann Surg 1995;221:133-148.
5. Robinson EK, Lee JE, Pisters PWT, Evans DB. Reoperative pancreaticoduodenectomy for periampullary carcinoma. Am J Surg 1996;172:432-438.
6. Cusack JC, Fuhrman GM, Lee JE, Evans DB. Management of unsuspected tumor invasion of the superior mesenteric-portal venous confluence at the time of pancreaticoduodenectomy. Am J Surg 1994;168:352-354.
7. Moore GE, Sako Y, Thomas LB. Radical pancreaticoduodenectomy with resection and reanastomosis of the superior mesenteric vein. Surgery 1951;30:550-553.
8. Freeny PC, Traverso LW, Ryan JA. Diagnosis and staging of pancreatic adenocarcinoma with dynamic computed tomography. Am J Surg 1993;165:600-606.
9. Gloor B, Todd KE, Reber HA. Diagnostic workup of patients with suspected pancreatic carcinoma. Cancer 1997;79:1780-1786.
10. Evans DB, Lee JE, Pisters PWT. Pancreaticoduodenectomy (Whipple operation) and total pancreatectomy for cancer. In Nyhus LM, Baker RJ, Fischer JF, eds. Mastery of Surgery, 3rd ed. Boston: Little, Brown, 1997, pp 1233-1249.
11. Fuhrman GM, Leach SD, Staley CA, et al. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Ann Surg 1996;223:154-162.
12. Harrison LE, Klimstra DS, Brennan MF. Isolated portal vein involvement in pancreatic adenocarcinoma: A contraindication for resection? Ann Surg 1996;224:342-349.
13. Leach SD, Lee JE, Charnsangavej C, Cleary KR, Lowy AM, Fenoglio CJ, Pisters PWT, Evans DB. Patient survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head. BrJ Surg 1998;85:611-617.
14. Furukawa H, Kosuge T, Mukai K, et al. Helical computed tomography in the diagnosis of portal vein invasion by pancreatic head carcinoma. Arch Surg 1998;133:61-65.
15. Loyer EM, David CL, Dubrow RA, et al. Vascular involvement in pancreatic adenocarcinoma: Reassessment by thin-section CT. Abdom Imaging 1996;21:202-206.
16. Spitz FR, Abbruzzese JL, Lee JE, et al. Preoperative and post-operative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol 1997;15:928-937.
17. Evans DB, Termuhlen PM, Byrd DR, et al. Intraoperative radiation therapy following pancreaticoduodenectomy. Ann Surg 1993;218:54-60.
18. Fuhrman G, Charnsangavej C, Abbruzzese JL, Martin R, Fenoglio CJ, Evans DB. Thin-section contrast enhanced computed tomography accurately predicts resectabiliry of malignant pancreatic neoplasms. Am J Surg 1994;167:104-111.
19. Cattell RB, Braasch JW. A technique for the exposure of the third and fourth portions of the duodenum. Surg Gynecol Obstet 1960;11:379-380.
20. Cameron JC. Rapid exposure of the portal and superior mesenteric veins. Surg Gynecol Obstet 1993;176:395-398.
21. Evans DB, Lee JE, Leach SD, et al. Vascular resection and intraoperative radiation therapy during pancreaticoduodenectomy: Rationale and technique. Adv Surg 1996;29:235-262.
22. Fortner J. Technique of regional subtotal and total pancreatectomy. Am J Surg 1985;150:593-600.
23. Leach SD, Davidson BS, Ames FC, Evans DB. Alternative method for exposure of the retropancreatic mesenteric vasculature during total pancreatectomy. J Surg Oncol 1996;61: 163-165.
24. Staley CA, Cleary KA, Abbruzzese JA, et al. Need for standardized pathologic staging of pancreaticoduodenectomy specimens. Pancreas 1996;12:373-380.
25. Klempnauer J, Ridder GJ, Bektas H, Pichlmayr R. Surgery for exocrine pancreatic cancer - Who are the 5- and 10-year survivors? Oncology 1995;52:353-359.
26. Nitecki SS, Sarr MG, Colby TV, van Heerden JA. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 1995;221:59-66.
27. Trade M, Schwall G, Saeger H. Survival after pancreaticoduodenectomy: 118 consecutive resections without an operative mortality. Ann Surg 1990;211:447-458.
28. Willet CG, Lewandrowski K, Warshaw AL, et al. Resection margins in carcinoma of the head of the pancreas: Implications for radiation therapy. Ann Surg 1993;217:144-148.
29. Yea CJ, Cameron JL, Lillemore KD, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann Surg 1995;221:721-733.
30. Gastrointestinal Tumor Study Group. A multi-institutional comparative trial of radiation therapy alone and in combination with 5-fluorouracil for locally unresectable pancreatic carcinoma. Ann Surg 1979;189:205-208.
31. Brodsky JT, Turnbull ADM. Arterial hemorrhage after pancreaticoduodenectomy, the "sentinel bleed." Arch Surg 1991; 126:1037-1040.
32. Sindelar WF. Clinical experience with regional pancreatectomy for adenocarcinoma of the pancreas. Arch Surg 1989; 124:127-132.
33. Launois B, Franci J, Bardaxoglou E, et al. Total pancreatectomy for ductal adenocarcinoma of the pancreas with special reference to resection of the portal vein and multicentric cancer. World J Surg 1993;17:122-127.
34. Allema JH, Reinders ME, vanGulik TM, et al. Portal vein resection in patients undergoing pancreaticoduodenectomy for carcinoma of the pancreatic head. Br J Surg 1994;81:1642-1646.
35. Fortner JG, Klimstra DS, Senie RT, Maclean BJ. Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy. Ann. Surg 1996;223:147-153.
36. Roder JD, Stein HJ, Siewert JR. Carcinoma of the periampullary region: Who benefits from portal vein resection? Am J Surg 1996;171:170-175.
37. Mukaiya M, Hirata K, Satoh T, et al. Lack of survival benefit of extended lymph node dissection for ductal adenocarcinoma of the head of the pancreas: Retrospective multi-institutional analysis in Japan. World J Surg 1998;22:248-253.